Skip to main content
Menu
FI
clinical genomic services

Revvity Omics Clinical Services

Revvity Omics is a global leader in genomic testing focused on rare inherited diseases, newborn screening, and hereditary cancers. Our services support the full continuum of care from preconception and prenatal to neonatal, pediatrics, and adult.

Revvity Omics - a one-stop-shop solution for your testing needs

Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, we answer complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families.

Login to your portal

View your testing results and order history within your account.

Explore testing services

Search for our testing catalog for test names, area of interests or keywords.

promotional banner

End your patient's diagnostic odyssey now!

Explore our ultrarapid whole genome sequencing

Our comprehensive Whole Genome Sequencing (WGS) offers a range of features, including mitochondrial genome sequencing, biochemical testing, cCMV analysis, CNV detection, and more. With a turnaround time of 5-8 days and flexible sample types, included dried blood spots, our service is the most convenient and efficient option for all your needs.

Why choose Revvity Omics

acceleration
Acceleration

With over 30 years of expertise, our team, led by renowned geneticists, are pioneering newborn screening and genomic services by employing state-of-the-art NGS technologies.

confidence
Confidence

We prioritize rapid results delivery, boasting industry-leading Turn-Around-Times (TATs) for panels, exomes, and genomes. Our comprehensive and flexible testing menu helps you to find the right test tailored to the patient's needs, supported by multiple sample types for swift and timely collection.

accessibility
Accessibility

We are dedicated to passing on cost savings achieved through efficient automation to our clients. Our industry-leading pricing structures, covering various testing platforms from genome to targeted single-site testing, provide cost certainty with transparent pricing based on the specific testing platform, whether it's a panel, exome, or genome.

Who we serve

1 of 3

This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.

Contact Revvity Omics for more information